Skip to main content

Heiner Dreismann and Charles Woler

NovellusDx has appointed Heiner Dreismann and Charles Woler to its board of directors. Dreismann currently serves on the boards of several public and private healthcare companies. Previously, he held several senior positions with Roche Group, including president and CEO of Roche Molecular Systems and head of global business development for Roche Diagnostics. Woler previously served as CEO of Roche France, CEO of SmithKline Beecham's European pharmaceutical business, CEO of Cadus Pharmaceuticals, CEO of Neruo3d and Endotis Pharma, and recently Biomnis.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.